Mayne Pharma 2014 Annual Report GO

Drug Delivery

With established oral drug delivery experience and proprietary technologies, clients receive products that have developmental, regulatory and marketing exclusivity.


Mayne Pharma has a range of branded and generic products currently on market in various countries, a number of products filed with regulatory agencies around the world and a growing pipeline of further products under development.


Through the integration of Mayne Pharma’s proprietary technologies, manufacturing capabilities and intimate knowledge of product markets, customers are provided with tailored pharmaceutical solutions.


Over the last 40 years, through an established GMP accredited manufacturing facility, Mayne Pharma has been involved with commercial contract manufacturing of oral products, as well as commercial manufacture of in house products.

To Top